VitaGuard™ Precision Oncology partnership ushers in a breakthrough in cancer diagnostics. BioNexus Gene Lab Corp. has entered a strategic cross‑equity alliance with Singapore’s Fidelion Diagnostics to commercialise VitaGuard™ across ASEAN. VitaGuard™ Precision Oncology Alliance: A Landmark Deal BGLC will acquire a stake in Fidelion and secure...

Myriam Giancarli represent a pragmatic approach to transforming healthcare access across Africa while offering investors a credible path to sustainable impact. Although international discourse often frames healthcare as a universal right, the reality remains stark: since January, resurgent outbreaks of cholera and mpox have...

She doesn’t do talk shows. She doesn’t grace lifestyle magazine covers. Yet behind the closed doors of Morocco’s boardrooms, the name Myriam Giancarli is increasingly whispered as one to watch. At the helm of Pharma 5, one of the kingdom’s leading private labs, this 44-year-old...

Klotho Neurosciences ALS gene therapy KLTO-202 is advancing through a critical phase of manufacturing and process development, positioning the company for early-stage clinical trials by Q3 2026. This significant milestone reflects Klotho Neurosciences, Inc. (NASDAQ: KLTO)'s ongoing commitment to tackling amyotrophic lateral sclerosis (ALS),...